Mineral-based nanoparticles for arthritis treatment
MetadataShow full item record
Aspects of the invention are directed to mineral-based nanoparticles comprising silicate nanoparticles that induce human mesenchymal stem cells (hMSCs) into a cartilage-lineage through the upregulation of cartilage-specific genes resulting in the transformation of the cell phenotype into that of a chondrocyte, i.e., a cartilage producing cell. The silicate nanoparticles are synthesized through a process where the precipitate of sodium silicate is mixed with one or more elements and compounds and milled into nanoparticles.
Gaharwar, Akhilesh K.; Carrow, James K. (1/26). Mineral-based nanoparticles for arthritis treatment. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from